BibTex RIS Cite
Year 2009, Volume: 43 Issue: 3-4, 99 - 106, 24.07.2012

Abstract

References

  • Ganio C, Tenewitz FE, Wilson RC, Mayles BG. The treatment o f chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg, 1993: 32: 263-268.
  • Wirthlin MR. Growth substances: potential use in periodontics. J West Soc Periodontal Abstr, 1989: 37: 101-125.
  • Rudkin GH, Miller TA. Growth factors in surgery. Plastic Reconstr Surg, 1996: 97: 469476.
  • Pierce GF, Mustoe TA , Altrock BW, Deuel TF, Thomason A. Role o f platelet-derived growth factor in wound healing. J Cell Biochem, 1991: 45: 319-326.
  • Carlson ER. Bone grafting the jaws in the 21st century: The use o f platelet-rich platelet-rich plasma and bone morphogenetic protein. Alpha Omegan, 2000: 93: 26-30.
  • Cohen S. Isolation of submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Client, 1962: 237: 1555-1559.
  • Horn DB. Maisel RH. Angiogenesis growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol, 1992: 101: 349-354.
  • Knighton D. Doucette M , Fiegel VD , Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res, 1988: 266: 319-329.
  • Marx RE. Carlson ER, Eichstaedt R M . Schimmele SR, Strauss .IE, Georgeff KR. Platelet rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1988: 85: 638-646.
  • Anitue E. Plasma rich in growth factors: Prelimanary results of use in the preparation o f future sites for implants. Int J Oral Maxillofac Implants. 1999: 14: 529-535.
  • Garg AK . The use o f platelet-rich plasma to enhance the success o f bone grafts around dental implants. Dental Implantol Update, 2000: 11: 17-21.
  • Rosenberg ES, Torosian J. Sinus grafting using platelet-rich plasma-initial case presentation. Pract Periodontics Aesthet Dent. 2000: 12: 843¬ 850.
  • Choukroun J, Adda F, Schoeffler C, Vervelle A. l ine opportunite en paro-implantologie: le PRF. Implantodontie. 2001: 42: 55-62.
  • Dohan DM , Choukroun .1, Diss A, Dohan SL, Dohan AJJ. Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I : Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E37-44.
  • Dohan DM , Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II : Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E45-50.
  • Dohan DM , Choukroun J, Diss A. Dohan SL. Dohan AJJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III : Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E51-55.
  • Choukroun J, Diss A, Simonpieri A, Girard A¬ O, Schoeffler C. Dohan SL, Dohan AJJ, Mouhyi .1, Dohan DM . Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: 56-60.
  • Choukroun J, Diss A, Simonpieri A, Girard AO, Schoeffler C. Dohan SL, Dohan AJJ, Mouhyi J, Dohan DM . Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations o f PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: 299-303.
  • Sunitha Raja V, Munirathnam Naidu M . Platelet-rich fibrin: Evolution of a secondgeneration platelet concentrate. Indian J Dent Res, 2008: 19:42-46.
  • Mosesson MW , Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci, 2001: 936:1130.
  • Diss A, Dohan DM , Mouhyi J, Mahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008: 105: 572579.
  • Kfir E, Klir V, Eliav E, Kaluski E. Minimally invasive guided bone regeneration. J Oral Implantol.2007: 33: 205-210.

TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI

Year 2009, Volume: 43 Issue: 3-4, 99 - 106, 24.07.2012

Abstract

Son yıllarda büyüme faktörleri ve yara iyileşmesi üzerine etkilerini araştıran birçok çalışına yapılmaktadır. Pcriferal kandan elde edilen trombositler büyüme faktörlerinin ana kaynaklarıdır. Bu nedenle trombositten zengin biyomataryaller birçok klinik uygulamada kullanılmaktadır. Bu biyonıateryallcri hazırlamak için çeşitli teknikler kullanılmaktadır ve hazırlanan biyomateryallcr sıklıkla trombositten zengin plazma (PRP) olarak adlandırılmaktadır. Trombositten zengin fibrin (PRF) ikinci nesil trombositten zengin biyomatcryaldir. Bu makalede vaka örnekleri ile birlikle trombositten zengin biyomatervallerin hazırlanma teknikleri, klinik uygulamaları ve faydalarına dair bilgiler tartışılacaktır.

References

  • Ganio C, Tenewitz FE, Wilson RC, Mayles BG. The treatment o f chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg, 1993: 32: 263-268.
  • Wirthlin MR. Growth substances: potential use in periodontics. J West Soc Periodontal Abstr, 1989: 37: 101-125.
  • Rudkin GH, Miller TA. Growth factors in surgery. Plastic Reconstr Surg, 1996: 97: 469476.
  • Pierce GF, Mustoe TA , Altrock BW, Deuel TF, Thomason A. Role o f platelet-derived growth factor in wound healing. J Cell Biochem, 1991: 45: 319-326.
  • Carlson ER. Bone grafting the jaws in the 21st century: The use o f platelet-rich platelet-rich plasma and bone morphogenetic protein. Alpha Omegan, 2000: 93: 26-30.
  • Cohen S. Isolation of submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Client, 1962: 237: 1555-1559.
  • Horn DB. Maisel RH. Angiogenesis growth factors: their effects and potential in soft tissue wound healing. Ann Otol Rhinol Laryngol, 1992: 101: 349-354.
  • Knighton D. Doucette M , Fiegel VD , Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res, 1988: 266: 319-329.
  • Marx RE. Carlson ER, Eichstaedt R M . Schimmele SR, Strauss .IE, Georgeff KR. Platelet rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1988: 85: 638-646.
  • Anitue E. Plasma rich in growth factors: Prelimanary results of use in the preparation o f future sites for implants. Int J Oral Maxillofac Implants. 1999: 14: 529-535.
  • Garg AK . The use o f platelet-rich plasma to enhance the success o f bone grafts around dental implants. Dental Implantol Update, 2000: 11: 17-21.
  • Rosenberg ES, Torosian J. Sinus grafting using platelet-rich plasma-initial case presentation. Pract Periodontics Aesthet Dent. 2000: 12: 843¬ 850.
  • Choukroun J, Adda F, Schoeffler C, Vervelle A. l ine opportunite en paro-implantologie: le PRF. Implantodontie. 2001: 42: 55-62.
  • Dohan DM , Choukroun .1, Diss A, Dohan SL, Dohan AJJ. Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I : Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E37-44.
  • Dohan DM , Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II : Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E45-50.
  • Dohan DM , Choukroun J, Diss A. Dohan SL. Dohan AJJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III : Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: E51-55.
  • Choukroun J, Diss A, Simonpieri A, Girard A¬ O, Schoeffler C. Dohan SL, Dohan AJJ, Mouhyi .1, Dohan DM . Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: 56-60.
  • Choukroun J, Diss A, Simonpieri A, Girard AO, Schoeffler C. Dohan SL, Dohan AJJ, Mouhyi J, Dohan DM . Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations o f PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006: 101: 299-303.
  • Sunitha Raja V, Munirathnam Naidu M . Platelet-rich fibrin: Evolution of a secondgeneration platelet concentrate. Indian J Dent Res, 2008: 19:42-46.
  • Mosesson MW , Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci, 2001: 936:1130.
  • Diss A, Dohan DM , Mouhyi J, Mahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008: 105: 572579.
  • Kfir E, Klir V, Eliav E, Kaluski E. Minimally invasive guided bone regeneration. J Oral Implantol.2007: 33: 205-210.
There are 22 citations in total.

Details

Primary Language Turkish
Journal Section Case Reports
Authors

Nilüfer Bölükbaşı This is me

Selim Ersanlı This is me

Tayfun Özdemir This is me

Publication Date July 24, 2012
Published in Issue Year 2009 Volume: 43 Issue: 3-4

Cite

APA Bölükbaşı, N., Ersanlı, S., & Özdemir, T. (2012). TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI. Journal of Istanbul University Faculty of Dentistry, 43(3-4), 99-106.
AMA Bölükbaşı N, Ersanlı S, Özdemir T. TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI. J Istanbul Univ Fac Dent. July 2012;43(3-4):99-106.
Chicago Bölükbaşı, Nilüfer, Selim Ersanlı, and Tayfun Özdemir. “TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI”. Journal of Istanbul University Faculty of Dentistry 43, no. 3-4 (July 2012): 99-106.
EndNote Bölükbaşı N, Ersanlı S, Özdemir T (July 1, 2012) TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI. Journal of Istanbul University Faculty of Dentistry 43 3-4 99–106.
IEEE N. Bölükbaşı, S. Ersanlı, and T. Özdemir, “TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI”, J Istanbul Univ Fac Dent, vol. 43, no. 3-4, pp. 99–106, 2012.
ISNAD Bölükbaşı, Nilüfer et al. “TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI”. Journal of Istanbul University Faculty of Dentistry 43/3-4 (July 2012), 99-106.
JAMA Bölükbaşı N, Ersanlı S, Özdemir T. TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI. J Istanbul Univ Fac Dent. 2012;43:99–106.
MLA Bölükbaşı, Nilüfer et al. “TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI”. Journal of Istanbul University Faculty of Dentistry, vol. 43, no. 3-4, 2012, pp. 99-106.
Vancouver Bölükbaşı N, Ersanlı S, Özdemir T. TROMBOSİTTEN ZENGİN BİYOMATERYALLERİN ORAL İMPLANTOLOJİDE KULLANILMASI. J Istanbul Univ Fac Dent. 2012;43(3-4):99-106.